Qube Research & Technologies (QRT)’s Acumen Pharmaceuticals ABOS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $66.8K | Buy |
57,559
+35,424
| +160% | +$41.1K | ﹤0.01% | 2326 |
|
2025
Q1 | $24.3K | Sell |
22,135
-46,186
| -68% | -$50.8K | ﹤0.01% | 2459 |
|
2024
Q4 | $118K | Sell |
68,321
-14,381
| -17% | -$24.7K | ﹤0.01% | 2289 |
|
2024
Q3 | $205K | Buy |
82,702
+6,833
| +9% | +$16.9K | ﹤0.01% | 2152 |
|
2024
Q2 | $184K | Sell |
75,869
-91,719
| -55% | -$222K | ﹤0.01% | 2106 |
|
2024
Q1 | $679K | Buy |
167,588
+78,962
| +89% | +$320K | ﹤0.01% | 2018 |
|
2023
Q4 | $340K | Buy |
88,626
+62,513
| +239% | +$240K | ﹤0.01% | 2165 |
|
2023
Q3 | $108K | Buy |
+26,113
| New | +$108K | ﹤0.01% | 2211 |
|
2023
Q2 | – | Sell |
-44,385
| Closed | -$180K | – | 2254 |
|
2023
Q1 | $180K | Sell |
44,385
-8,978
| -17% | -$36.5K | ﹤0.01% | 1902 |
|
2022
Q4 | $288K | Buy |
53,363
+36,650
| +219% | +$198K | ﹤0.01% | 1598 |
|
2022
Q3 | $168K | Sell |
16,713
-5,546
| -25% | -$55.7K | ﹤0.01% | 1774 |
|
2022
Q2 | $105K | Buy |
+22,259
| New | +$105K | ﹤0.01% | 1920 |
|